Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Purchased by LPL Financial LLC

LPL Financial LLC raised its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 11.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 99,721 shares of the medical equipment provider's stock after purchasing an additional 10,122 shares during the quarter. LPL Financial LLC owned 0.05% of Zimmer Biomet worth $10,534,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the company. Geode Capital Management LLC grew its stake in shares of Zimmer Biomet by 2.6% during the third quarter. Geode Capital Management LLC now owns 4,879,385 shares of the medical equipment provider's stock valued at $524,942,000 after buying an additional 125,852 shares during the last quarter. Van ECK Associates Corp grew its position in Zimmer Biomet by 5.9% in the 4th quarter. Van ECK Associates Corp now owns 3,955,449 shares of the medical equipment provider's stock valued at $417,814,000 after acquiring an additional 218,688 shares during the last quarter. Equity Investment Corp increased its stake in Zimmer Biomet by 57.2% in the fourth quarter. Equity Investment Corp now owns 1,021,062 shares of the medical equipment provider's stock worth $107,855,000 after purchasing an additional 371,653 shares during the period. FMR LLC lifted its position in shares of Zimmer Biomet by 27.6% during the third quarter. FMR LLC now owns 750,336 shares of the medical equipment provider's stock worth $80,999,000 after purchasing an additional 162,384 shares during the last quarter. Finally, Sei Investments Co. boosted its stake in shares of Zimmer Biomet by 2.6% during the fourth quarter. Sei Investments Co. now owns 715,372 shares of the medical equipment provider's stock valued at $75,565,000 after purchasing an additional 18,433 shares during the period. Institutional investors own 88.89% of the company's stock.

Remove Ads

Insider Transactions at Zimmer Biomet

In related news, SVP Lori Winkler sold 1,443 shares of the company's stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $104.40, for a total transaction of $150,649.20. Following the completion of the transaction, the senior vice president now owns 8,768 shares in the company, valued at $915,379.20. This represents a 14.13 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.95% of the company's stock.

Zimmer Biomet Stock Performance

NYSE:ZBH traded down $2.12 during trading hours on Tuesday, reaching $102.73. The company had a trading volume of 1,995,360 shares, compared to its average volume of 1,597,520. The firm has a market cap of $20.45 billion, a PE ratio of 23.08, a price-to-earnings-growth ratio of 1.95 and a beta of 0.84. Zimmer Biomet Holdings, Inc. has a 1-year low of $97.69 and a 1-year high of $129.50. The business's 50 day moving average price is $106.80 and its 200-day moving average price is $107.16. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.91 and a quick ratio of 0.99.

Zimmer Biomet (NYSE:ZBH - Get Free Report) last posted its earnings results on Thursday, February 6th. The medical equipment provider reported $2.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.30 by $0.01. Zimmer Biomet had a net margin of 11.77% and a return on equity of 12.99%. During the same period in the previous year, the company posted $2.20 earnings per share. Research analysts forecast that Zimmer Biomet Holdings, Inc. will post 8.22 EPS for the current year.

Zimmer Biomet Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be given a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.93%. The ex-dividend date of this dividend is Monday, March 31st. Zimmer Biomet's dividend payout ratio (DPR) is presently 21.57%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. JMP Securities reiterated a "market outperform" rating and set a $140.00 price objective on shares of Zimmer Biomet in a report on Friday, February 7th. Truist Financial reiterated a "hold" rating and issued a $113.00 price target (down previously from $118.00) on shares of Zimmer Biomet in a report on Monday, February 10th. Barclays reduced their price objective on Zimmer Biomet from $118.00 to $112.00 and set an "underweight" rating on the stock in a report on Monday, February 10th. Royal Bank of Canada cut their target price on shares of Zimmer Biomet from $130.00 to $125.00 and set an "outperform" rating on the stock in a research report on Friday, February 7th. Finally, JPMorgan Chase & Co. upgraded shares of Zimmer Biomet from a "neutral" rating to an "overweight" rating and increased their price objective for the company from $125.00 to $128.00 in a research note on Tuesday, December 17th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and nine have assigned a buy rating to the company. According to MarketBeat.com, Zimmer Biomet has an average rating of "Hold" and an average target price of $124.15.

About Zimmer Biomet

Zimmer Biomet Holdings, Inc, together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.